烟草在线据NACS报道编译　　3月6日，美国食品与药品监督管理局（FDA）的零售商研讨会仅仅讨论了小型业主提出的关于FDA烟草法规的一些最常见问题。该次会议并未披露任何新的信息，仅简单重申了烟草零售商的法律义务。以下是研讨会内容概览：

　　·广告：卷烟广告不能包含“淡味”、“超淡味”等形容词描述，且必须包含卫生部的健康警示内容。

　　·图片警语标签：根据2月底诉讼法庭的裁决，FDA要求卷烟包装印刷图片警语的规定是违宪的，在诉讼作出最终裁决前并不期望烟草零售商和制造商们执行此规定。

　　·免费样品：零售商不能提供卷烟的免费样品，而无烟烟草产品的免费样品仅允许在禁止18岁以下青少年进入的店铺中提供。

　　·赠品：除卷烟或无烟烟草产品打折出售外，零售商禁止向购买卷烟或无烟烟草产品者提供任何赠品或优惠（免费火柴除外）。同时，零售商不得向非烟草产品购买者（例如汽油购买者）提供任何卷烟或无烟烟草产品的打折优惠。FDA向全国大学商店协会（NACS）指出，消费者或许会通过购买卷烟或无烟烟草产品要求记录其“忠诚度”，但零售商不能以任何“忠诚度累计”或类似的项目记录消费者购买卷烟或无烟烟草产品的次数。

　　·电子卷烟：去年对于电子卷烟并非“药品或医药设备”因此不遵守这些产品严格的法律措施的此法裁决，尽管FDA没有提起上诉，但是FDA仍然有权对电子卷烟制定与卷烟产品类似的法律法规，也不排除将来出台此类法规的可能性。

　　FDA并未宣布下一次烟草零售商研讨会召开的时间和地点。您若错过了3月6日的研讨会，可以在FDA网站观看在线视频。

　　如果您想了解更多关于FDA民事赔偿程序，或零售商的职责及遵守要求等内容，请注册参加3月14日由NACS和We Card主办的研讨会。

FDA Reiterates Tobacco Retailers' Obligations

NACS
Mar 7, 2012

　　The Food and Drug Administration (FDA) webinar for retailers reviewed some of the most frequently asked questions small businesses have asked regarding FDA's tobacco regulations. The March 6 webinar did not reveal any new information, but simply reiterated tobacco retailers' legal obligations. Here is an overview:

　　·Advertisements: Cigarette advertisements may not include descriptors ("light," "ultra-light," etc.) and must include the Surgeon General's warning.

　　·Graphic warning labels: In light of last week's litigation court ruling that FDA's requirements for graphic warning labels on cigarette packages were unconstitutional, tobacco retailers and manufacturers are not expected to comply with that rule's mandates during the pending litigation.

　　·Free Samples: Retailer may not distribute free samples of cigarettes, and free samples of smokeless tobacco may only be distributed in facilities where minors under the age of 18 are not permitted to enter.

　　·Gifts: Retailers are prohibited from offering any benefit to a customer in return for purchasing cigarettes or smokeless tobacco (except for free matches) unless that benefit is discounted cigarettes or smokeless tobacco. Also, retailers may not offer discounted cigarettes or smokeless tobacco in return for any non-tobacco purchase (such as gasoline). FDA has indicated to NACS, however, that customers may redeem "loyalty points" by buying cigarettes or smokeless tobacco, but retailers may not count purchases of cigarettes or smokeless tobacco as points in any such loyalty or affinity program.

　　·E-Cigarettes: Although FDA did not appeal last year's judicial ruling that e-cigarettes are not "drugs or devices" and thus not subject to those products' strict regulatory treatment, FDA indicated that it has the authority to issue regulations regulating e-cigarettes as cigarettes, and that it may propose such regulations in the future.

　　FDA has not announced when its next tobacco compliance webinar for retailers will take place. If you missed the March 6 webinar, it is online.

　　If you want to learn more about how to navigate FDA's Civil Monetary Penalty Process and better understand retailer responsibilities and compliance requirements, register for the free March 14 webinar sponsored by NACS and We Card.